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 ABSTRACT 
 During a mammary immune response, the integrity 
of the blood-milk barrier is negatively affected and 
becomes leaky. The aim of the present study was to 
demonstrate the blood origin, and to investigate 
changes in the concentration, of various constituents 
including immunoglobulins in blood and milk during 
the early phase of lipopolysaccharide (LPS)-induced 
mastitis. Five lactating dairy cows received continu-
ous β-hydroxybutyrate (BHBA) clamp infusions to 
maintain elevated BHBA blood concentrations (1.5 to 
2.0 mmol/L) from 48 h before and 8 h after LPS ad-
ministration. One udder quarter was infused with 200 
μg of Escherichia coli LPS. A second quarter served 
as control. Milk and blood samples were taken hourly 
for 8 h postchallenge (PC). The somatic cell count in 
LPS-challenged quarters was increased from 4 h PC 
to the end of the experiment compared with control 
quarters. In LPS-challenged quarters, l-lactate, BHBA, 
lactate dehydrogenase (LDH), IgG1, and IgG2 were in-
creased at 3 h PC and remained elevated until the end 
of experiment (8 h PC) compared with control quar-
ters. In addition, the optical density values in milk in a 
nonquantitative ELISA for antibodies directed against 
bluetongue virus (used as a measure of nonspecific an-
tibody transfer; all animals were vaccinated) increased 
and, thus, indicates an increase in these antibodies in 
response to LPS treatment. l-Lactate concentration 
also increased in blood 2 h PC and in the milk of con-
trol quarters during the experiment from 3 h PC. A 
second experiment was conducted in vitro to investi-
gate a possible contribution from destructed milk cells 
to l-lactate concentration and activity of LDH in milk. 
Aliquots of milk samples (n = 8) were frozen (−20°C) 
or disrupted with ultrasound, respectively. Freeze thaw-
ing and ultrasound treatment increased LDH in milk 
samples, but had no effect on l-lactate concentrations. 
Results suggest that intramammary infusion of LPS 
induces a systemic response, as evidenced by an eleva-
tion of blood l-lactate concentration. The concomitant 
changes of all investigated components suggest that 
they were blood derived. However, the increase in blood 
components in the milk is not necessarily supportive of 
the mammary immune system, and likely a side effect 
of reduced blood-milk barrier integrity. 
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 INTRODUCTION 
 In the bovine mammary gland, invading pathogens 
induce an immune response by stimulating the innate 
immune system. It is generally accepted that the main 
effectors of the mammary immune defense against 
mastitis-causing bacteria are blood derived polymor-
phonuclear neutrophils (PMN; Burton and Erskine, 
2003). Their infiltration into the mammary gland and 
their accumulation in milk is measured as an increase 
in the milk SCC, which is widely used as a measure of 
hygienic milk quality (Harmon, 1994). 
 During the early acute stage of mammary inflamma-
tion a leakage of blood constituents occurs because of 
an alteration in the blood-milk barrier (Burton and Er-
skine, 2003). In addition to SCC, the concentrations of 
several other components change in milk in response to 
inflammation of the mammary gland, not all of which 
contribute to host defense. 
 Milk l-lactate (hereafter referred to as lactate) and 
the enzyme lactate dehydrogenase (LDH) increase in 
milk during IMI and have been considered indicators 
of mastitis, even though the immunological contribu-
tion of these factors is not known (Davis et al., 2004; 
Chagunda et al., 2006). Immunoglobulin G is the major 
immunoglobulin in ruminant milk (Butler, 1983) and 
consists of 2 subclasses: IgG1 and IgG2. Immunoglobu-
lin G1 is the predominant antibody type in milk from 
healthy quarters because of an active, selective IgG1
transport across the blood-milk barrier, likely mediated 
by the neonatal Fc receptor (FcRn) receptor system 
(Baker et al., 2009). In mastitic milk, IgG2 increases 
in concentration (Caffin and Poutrel, 1988) and plays 
a critical role in mammary immune defense against 
mastitis pathogens (Burton and Erskine, 2003). How-
 Concomitant lipopolysaccharide-induced transfer of blood-derived 
components including immunoglobulins into milk 
 M.  Lehmann ,  O.  Wellnitz , and  R. M.  Bruckmaier 1
 Veterinary Physiology, Vetsuisse Faculty University of Bern, Bremgartenstrasse 109a, CH-3001 Bern, Switzerland 
 
  
 Received February 3, 2012.
 Accepted October 23, 2012.
  1 Corresponding author:  rupert.bruckmaier@vetsuisse.unibe.ch 
s
o
u
r
c
e
:
 
ht
tp
:/
/b
or
is
.u
ni
be
.c
h/
44
54
1/
 
| 
do
wn
lo
ad
ed
: 
13
.3
.2
01
7
890 LEHMANN ET AL.
Journal of Dairy Science Vol. 96 No. 2, 2013
ever, antibodies that are not directed against mastitis-
causing pathogens are also nonspecifically transferred 
into the mammary gland and can be found in the milk 
of healthy udders (e.g., antibodies against the bovine 
viral diarrhea virus or those against bluetongue virus; 
Kramps et al., 1999; Kramps et al., 2008). After the 
bluetongue disease outbreak in Northern Europe in 
2006, Swiss cows were vaccinated against the blue-
tongue virus serotype 8 between 2008 and 2010.
Another blood constituent without any obvious ben-
efit for immune defense in the mammary gland is the 
ketone body BHBA, which is produced by the liver. A 
significant correlation of 0.66 between BHBA in blood 
and milk was described by Enjalbert et al. (2001); 
however, information on its possible role in mammary 
gland health was not provided. Intramammary admin-
istration of LPS from Escherichia coli, a common mas-
titis pathogen, is a well-established method to experi-
mentally induce mastitis under defined conditions for 
studying the immune response of the mammary gland 
(Schmitz et al., 2004; Baumert et al., 2009; Wellnitz 
et al., 2011). In those studies, LPS from different E. 
coli strains were shown to require different concentra-
tions to induce comparable immune responses of the 
mammary gland. This effect is, besides differences in 
individual responsiveness, due to variations in the fine 
structure of LPS (Rietschel et al., 1994).
The objective of the present study was to document 
changes in milk SCC and lactate, BHBA, LDH, IgG1, 
and IgG2 concentrations in milk and to contrast these 
changes to those in blood during the first hours of LPS-
induced mastitis. We hypothesized that the increase in 
lactate concentration, along with that of other compo-
nents that are expected to originate from blood, is a 
result of loss of the integrity of the blood-milk barrier. 
An additional experiment was performed to establish 
the origin of lactate in milk.
MATERIALS AND METHODS
Experiment 1: LPS-Induced Mastitis
Animals and Management. Five mid-lactation 
dairy cows (Holstein) in their third to fourth lactation 
were used in these studies. While maintained in a ties-
tall, foremilk samples were taken from each quarter ap-
proximately 3 wk before, 1 wk before, and immediately 
before the start of the experiment to verify a constantly 
low SCC (<150,000 cells/mL). A DeLaval cell counter 
(DCC; DeLaval International AB, Tumba, Sweden) was 
used to measure SCC. All cows had been immunized 
against the bluetongue virus serotype 8 (Bovilis BTV8; 
Intervet International BV, Boxmeer, the Netherlands) 
approximately 1 yr before the experiment as a part of 
a national vaccination campaign.
Experimental Design. dl-β-Hydroxybutyrate 
solution (2.14 M; H6501; Sigma-Aldrich, Buchs, Swit-
zerland) was infused 48 h before and during the LPS 
challenge to induce hyperketonemia (1.5 to 2.0 mmol 
of BHBA/L in the plasma) throughout the experiment 
as described by Zarrin et al. (2012). Two intravenous 
catheters (Cavafix Certo Splittocan; B. Braun Melsun-
gen AG, Melsungen, Germany), one inserted into each 
jugular vein, were used to infuse BHBA and to take 
blood samples, respectively.
On the day of challenge and after the morning milk-
ing, cows were intramammarily infused with 200 μg of 
E. coli LPS into the left front quarter (LPS from E. coli 
serotype O26:B6; Sigma-Aldrich), diluted in 10 mL of 
sterile saline solution (9 g/L). The right front quarter 
was used as a control and treated with 10 mL of the 
saline solution. Milk samples (~20mL) were hand col-
lected for an immediate SCC measurement that contin-
ued hourly for 8 h postchallenge from the experimental 
quarters after discarding the first 3 squirts of milk. Milk 
samples were frozen at −20°C for later analyses. Skim 
milk was prepared by centrifugation at 4,000 × g for 15 
min and milk serum was prepared by centrifugation of 
the skim milk at 14,000 × g for 30 min.
Blood samples were collected at times coinciding with 
milk sample collection. Blood was collected into tubes 
containing FE sodium fluoride/tripotassium EDTA 
(Greiner Bio-One GmbH, Kremsmünster, Austria) as 
anticoagulant. Tubes were stored briefly on wet ice and 
then centrifuged for 20 min at 3,000 × g. Plasma was 
collected and frozen at −20°C until analyses.
Lactate dehydrogenase activity, lactate concentra-
tion, and BHBA concentration were measured in milk 
serum and blood plasma using the test kits LDH IFCC 
(Axon Lab AG, Baden, Switzerland), Lactate PAP 
(bioMérieux SA, Marcy l’Étoile, France) and Ranbut 
(Randox Laboratories Ltd., London, UK), respectively, 
with an automated analyzer (Cobas Mira; Roche Diag-
nostics, Basel, Switzerland) according to the manufac-
turer’s instructions.
The IgG1 and IgG2 concentrations in skim milk and 
blood plasma were measured using bovine IgG1 and 
IgG2 ELISA quantitation kits (Bethyl Laboratories 
Inc., Montgomery, TX) according to the manufacturer`s 
instructions, with the following slight modifications: 
after coating of plates overnight with anti-bovine 
IgG1/IgG2, the plates were washed using an auto-
matic washing system (microplate washer Columbus 
Pro; Tecan Group Ltd., Männedorf, Switzerland) and 
subsequently blocked with 150 μL/well of 5% fish skin 
gelatin (Sigma-Aldrich) in distilled water for 60 min at 
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room temperature. After washing, 100 μL of skim milk 
diluted in washing buffer (1:100 for IgG2 and 1:1000 
for IgG1) or blood plasma samples were added to each 
well. On the plate, the samples were diluted in 3 serial 
1:2 dilutions using a multichannel pipette. One control 
sample was added to each plate and was used for the 
calculation of coefficients of variation that reached 
10 and 20% within and between assays, respectively. 
Plates were incubated for 60 min at room temperature 
and subsequently washed as described above. Sheep 
anti-bovine IgG1/IgG2 horseradish peroxidase (HRP)-
conjugated antibody was diluted 1:15,000 and 1:10,000, 
respectively, in wash buffer and 100 μL of this solution 
was added to each well. The concentrations of IgG1 and 
IgG2 were calculated by extrapolating from a standard 
curve generated by a THERMOmax microplate reader 
(Molecular Devices, Basel, Switzerland).
The ELISA test kit INGEZIM BTV-MILK 12.BTV.
K1 (Inmunología y Genética Aplicada SA, Madrid, 
Spain) was used to determine anti-bluetongue virus 
antibodies in skim milk according to manufacturer`s in-
structions. Optical density (OD) values were measured 
at 450 nm by using the THERMOmax microplate 
reader (Molecular Devices).
Data Analysis. Data are presented as means ± 
standard error of the mean. Data for SCC, lactate 
concentration, and LDH activity were log-transformed 
(log10) to improve normality. Differences between LPS 
and control within each time point and differences be-
tween time points within one group were tested for sig-
nificance (P < 0.05) by ANOVA using PROC MIXED 
of SAS (SAS Institute Inc., Cary, NC; 2002–2008, Re-
lease 9.2). The model included time, treatment (LPS or 
control), the quarter within cow, and their interaction 
as fixed effects and the cow as repeated subject. For 
antibodies against anti-bluetongue virus in milk, OD 
values are presented in a descriptive way.
Experiment 2: Milk Cell Destruction
Experimental Design. To investigate the effect of 
milk cell destruction on the lactate concentration and 
LDH activity in milk, 8 quarter foremilk samples from 
2 different cows were collected during 1 morning milk-
ing. Three aliquots of each milk sample were treated 
differently: one aliquot was frozen at −20°C, a second 
was treated with ultrasound for 10 s at 100 W (Bran-
son Sonifier 150; Branson Ultrasonics Corp., Danbury, 
CT), and the third served as a control without any 
treatment (stored in the refrigerator at 4°C). Catalytic 
activity of LDH and lactate concentration were then 
detected in milk serum, prepared as described previ-
ously, using the test kits LDH IFCC (Axon Lab AG) 
and Lactate PAP (bioMérieux SA), respectively, in an 
autoanalyzer (Cobas Mira; Roche Diagnostics) accord-
ing to the manufacturer’s instructions.
Data Analysis. Data are presented as means ± 
standard error of the mean. For evaluation of changes 
of lactate and LDH through freezing and ultrasound, 
differences between treated and untreated samples were 
used. Differences between the treatments were tested 
for significance (P < 0.05) by ANOVA using PROC 
MIXED of SAS (8.02; SAS Institute Inc., Cary, NC). 
The model included treatment as a fix effect and the 
sample as repeated subject.
RESULTS
Experiment 1: LPS-Induced Mastitis
SCC. The SCC started to increase in LPS-treated 
quarters at 3 h PC and was significantly and continu-
ously elevated from 4 h PC until the end of the ex-
periment compared with control quarters (Figure 1A). 
Control quarter SCC was significantly elevated only at 
2 h PC when compared with 0 h.
Lactate. The lactate concentration in milk of LPS-
treated and control quarters (Figure 1B) was increased 
at 3 h PC (P < 0.0001 and P < 0.05, respectively) 
and reached concentrations similar to those observed in 
blood plasma (>1 mM) by 6 h PC, reaching a maximum 
at 7 h PC. This increase in lactate was greater in LPS-
treated quarters compared with control quarters (P < 
0.05). In 2 cows, the lactate concentrations in milk of 
LPS-treated quarters exceeded the values of those in 
blood. In the blood plasma, lactate concentration was 
higher at 2 h PC compared with the concentration at 
0 h (P < 0.05) and continued to increase steadily until 
the end of the experiment at 8 h PC.
BHBA. In 25 out of 90 milk samples, BHBA con-
centrations were below the detection limit (Figure 1C). 
In such cases half of the detection limit (0.05 mmol/L) 
was then used as a value for mathematical and statisti-
cal calculations. Significantly higher BHBA concentra-
tions were identified in LPS quarters compared with 
control quarters from 3 h PC and continued to increase 
until the end of the experiment. Control quarter BHBA 
concentration did not change. The BHBA blood con-
centration was not analyzed because it was controlled 
via a BHBA clamp infusion. At 0 h, the BHBA con-
centration in blood plasma was 16-fold higher (P < 
0.05) than in the milk. During the experiment, this 
ratio diminished to a 3-fold difference at 8 h PC, but 
did not reach the blood plasma concentrations during 
the experiment.
LDH. The LDH activity in milk of LPS-treated 
quarters (Figure 1D) was significantly higher at 3 h PC 
compared with control quarters and remained elevated 
892 LEHMANN ET AL.
Journal of Dairy Science Vol. 96 No. 2, 2013
until the end of the experiment, but did not reach the 
concentrations found in blood. The activity of LDH in 
blood plasma and milk from control quarters did not 
change throughout the experiment. At 0 h, the blood/
milk LDH ratio was 29:1, decreasing during the experi-
ment to 3:1 at 8 h PC.
IgG1 and IgG2. From 3 to 8 h PC, IgG1 and IgG2 
concentrations in milk of LPS-treated quarters were 
significantly higher compared with control quarters 
(Figure 1E and 1F). No changes in IgG1 and IgG2 
concentrations in blood plasma and milk of control 
quarters could be detected throughout the experiment. 
The blood:milk IgG1 and IgG2 ratios were 77:1 and 
554:1, respectively, before LPS challenge. At 8 h PC the 
blood:milk IgG1 and IgG2 ratios diminished to 17:1 and 
21:1, respectively. In addition, the ratio of IgG1:IgG2 in 
blood plasma and milk of treated and control quarters 
was calculated throughout the experiment (Figure 2). 
At 0 h, the ratio in milk from both treated and control 
quarters was approximately 4, whereas in blood, the 
ratio was 0.48. In the blood plasma, the ratio IgG1:IgG2 
was 1.0:2.1 and did not change throughout the experi-
ment. In the milk of the LPS-treated quarter, the ratio 
started to decrease at 2 h, and reached the level in 
Figure 1. Milk SCC (A), lactate (B), BHBA (C), lactate dehydrogenase (LDH; D), IgG1 (E), and IgG2 (F) concentrations in milk of control 
quarters (), LPS-challenged quarters (Δ), and in the blood plasma () of 5 cows. * indicates a significant (P < 0.05) difference between LPS 
and control quarters within each time point. Different lowercase letters (a–e) indicate significant differences between time points within control 
quarters; different uppercase letters (A–E) indicate significant differences between time points within LPS-challenged quarters; no letters indi-
cate no differences between time points. Data are presented as means ± SEM of 5 cows.
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blood plasma at 3 h PC, which was maintained until 
the end of experiment.
Anti-Bluetongue Virus Antibodies. The non-
quantitative test indicated that all examined milk sam-
ples were positive for anti-bluetongue virus antibodies 
(cut-off OD value for a positive result was 0.38). The 
OD values between 0 and 2 h PC ranged from 0.89 to 
1.46 in control quarters and from 0.87 to 1.49 in LPS-
challenged quarters. Between 3 and 8 h PC, the OD 
values ranged from 0.92 to 1.46 in control quarters but 
from 1.17 to 1.74 in LPS challenged quarters.
Experiment 2: Milk Cell Destruction
Freezing and thawing and ultrasound treatment sig-
nificantly increased the catalytic activity of LDH in 
milk by 44 and 50%, respectively. Freezing and thaw-
ing and ultrasound treatment had no effect on lactate 
concentrations in milk. (Figure 3)
DISCUSSION
In the present study, changes in various blood and 
milk components were quantified during the early phase 
of LPS-induced mastitis. The observed increase in SCC 
in response to intramammary LPS challenge has been 
shown before (Baumert et al., 2009; Wellnitz et al., 
2011). The slight increase in SCC in the 2 first hours in 
all quarters was also expected and regularly observed 
after milking (Wellnitz et al., 2011). Coinciding with 
the infiltration of PMN, the blood-milk barrier is ex-
pected to become leaky, allowing blood constituents to 
enter the lumen (Burton and Erskine, 2003) or, as has 
been shown for lactose, exit the lumen and enter the 
circulation (Bruckmaier et al., 2004). 
The hypothesis that increased passage of blood con-
stituents into milk occurs during mammary inflamma-
tion was supported by the present study. The increasing 
BHBA concentration in milk after LPS challenge must 
have been blood derived because it occurred only in 
animals that received a BHBA infusion to keep blood 
BHBA concentrations constantly elevated throughout 
the experiment. In cows with normal BHBA blood 
concentrations, the concentration in milk remained 
below the detection limit for both LPS-treated and 
control quarters (0.1 mmol/L; data not shown). The 
Figure 2. Ratios of IgG1:IgG2 in blood plasma () and milk of con-
trol quarters () and LPS-challenged (Δ) quarters. * indicates a sig-
nificant (P < 0.05) difference between LPS and control quarters within 
each time point. Different letters (a–c) indicate significant differences 
between time points within LPS-treated quarters; no letters indicate 
no differences between time points (control quarters and blood plas-
ma). Data are presented as means ± SEM of 5 cows.
Figure 3. Lactate concentration (A) and lactate dehydrogenase 
(LDH) activity (B) after different treatments (control, −20°C, and ul-
trasound) of quarter foremilk samples (n = 8). * indicates a significant 
difference (P < 0.05) between freezing or ultrasound treatment and 
control. Data are presented as means ± SEM of 8 samples.
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accumulation of BHBA in milk of LPS-treated quarters 
suggests that LPS-induced mastitis causes a loss of the 
blood-milk barrier integrity (Bannerman et al., 2004) 
and allows the BHBA molecules to pass through the 
barrier and to accumulate in milk. These results are in 
agreement with Nielsen et al. (2005) who found higher 
BHBA milk concentrations in diseased quarters com-
pared with healthy quarters. The other investigated 
parameters lactate, LDH, and immunoglobulins started 
to increase at the same time after LPS challenge as 
BHBA, which indicated that also these factors do, at 
least in part, originate from blood.
Experiment 2 showed that milk cell disruption (by 
freezing or by ultrasound) leads to increased LDH ac-
tivity in milk, which is in agreement with earlier studies 
(Kato et al., 1989; Lipperheide et al., 1995) whereas 
lactate did not significantly change. Milk LDH activ-
ity was thought to originate from the blood and to 
be a suitable indicator of increased permeability of 
the blood-milk barrier (Symons and Wright, 1974). In 
experiment 1, the blood:milk LDH ratio decreased in 
response to LPS challenge in a similar manner to that 
observed for BHBA, yet milk concentrations did not 
reach those observed in blood within the experimental 
period. This is possibly due to the large difference in 
the molecular weights (140 vs. 104 kDa). Our current 
finding suggests that the origin of LDH in milk may be 
attributable to both soluble LDH from blood as well as 
disrupted leukocytes (Kato et al., 1989) and epithelial 
cells (Bogin et al., 1977; Zank and Schlatterer, 1998).
Lactate is known to increase in milk during mastitis 
(Davis et al., 2004). However, the origin of the lactate 
remained unclear. Our data demonstrated that lactate 
concentration increased also in blood in response to in-
tramammary LPS administration. Intravenous LPS ad-
ministration has been shown to increase blood lactate 
concentrations in cows (Giri et al., 1990). In the present 
study, lactate concentrations in milk of control quarters 
increased slightly but concomitantly with blood lactate 
concentration. This is in contrast to SCC, BHBA, LDH, 
IgG1, IgG2, and anti-bluetongue virus antibodies, which 
remained relatively stable in blood. This underlines the 
suggestion that the majority of lactate in healthy quar-
ters originates from blood.
Lactate concentrations in milk of LPS-treated quar-
ters increased to comparable levels to those in blood 
plasma (at 6 h PC), and, surprisingly, in 2 cows the 
concentrations of lactate in milk of LPS-treated quar-
ters exceeded the concentrations of lactate in blood. 
This is in contrast to the concentrations of BHBA and 
LDH, which were always higher in blood than in milk. 
This observation may be explained by additional lac-
tate production and release during anaerobic metabo-
lism by milk and epithelial cells in the gland (Mayer et 
al., 1988; Silanikove et al., 2011), whereas the results of 
experiment 2 show that the lactate produced by cells 
in the milk appeared to be released from these cells 
directly after synthesis. In addition, the small size of 
the lactate molecule (90 Da) as compared with the 
other investigated constituents may allow for increased 
transfer from blood into milk. The existence of a spe-
cific transmembrane transport mechanism for lactate 
via aquaporins is likely, as aquaporins transport lactate 
(Conde et al., 2010), and aquaporins are present in the 
bovine mammary gland (Mobasheri et al., 2011).
In the present study, IgG1 was the predominant IgG 
antibody subclass in milk before LPS challenge, which 
is in agreement with earlier studies (Guidry et al., 1980; 
Butler, 1983). It is likely that the specific transport 
mechanism for IgG1, which is prevalent in prepartum 
colostrum formation, remains weakly expressed during 
lactation. Both IgG1 and IgG2 increased simultane-
ously 3 h after intramammary LPS challenge and the 
IgG1:IgG2 ratio reached a similar milk ratio to that 
observed in blood. Immunoglobulin G2 is considered to 
be the main opsonic antibody for neutrophil phagocy-
tosis and is, therefore, most important for mammary 
immune defense against mastitis pathogens (Hill et 
al., 1983; Leitner et al., 2000). Both IgG1 and IgG2 
milk concentrations increased 3 h PC, along with SCC, 
BHBA, LDH, and lactate, indicating an unspecific 
transfer through the opening of the blood-milk barrier.
The results of the ELISA used for the detection of 
antibodies against bluetongue virus in milk can be 
interpreted solely as positive, doubtful, or negative ac-
cording to the manufacturer. However, the higher OD 
values measured in milk of LPS-challenged quarters 
after 3 h PC indicate an increase in antibodies against 
bluetongue virus. Thus, a nonspecific accumulation of 
various antibodies in the mammary gland during mas-
titis is likely. Obviously, during the alteration of the 
blood-milk barrier, antibodies, regardless of specific-
ity, are able to pass the blood-milk barrier. This is in 
agreement with Charlier et al. (2006) who found higher 
Ostertagia ostertagi antibody levels in milk of experi-
mentally infected quarters. They described that an 
acute mastitis causes a flow of specific and nonspecific 
antibodies from blood into milk. These finding could be 
important to understand the effectiveness of vaccina-
tions against mastitis pathogens.
CONCLUSIONS
All investigated parameters appear to be blood de-
rived and their increase in milk occurs in parallel with 
the increase in SCC. The integrity of the blood-milk 
barrier is reduced during the early phase of LPS-in-
duced mastitis. This allows various blood constituents 
Journal of Dairy Science Vol. 96 No. 2, 2013
BLOOD COMPONENTS IN MILK DURING MASTITIS 895
to pass through the blood-milk barrier to milk, which 
may or may not support the mammary immune re-
sponse. Intramammary LPS infusion also induces a 
systemic immune reaction, shown by our evidence of an 
increase in blood lactate concentration that affects the 
lactate in milk of control quarters. The increase of some 
specific IgG in milk during mammary immune response 
may not be supportive for the mammary immune sys-
tem and is, at least partially, just a result of reduced 
integrity of the blood-milk barrier. However, these 
results show that the degree to which the blood-milk 
barrier integrity is compromised by a mastitis pathogen 
influences the milk composition and content of blood 
components. The combat against mastitis pathogens 
may be improved by the alteration of the blood-milk 
barrier, especially if specific antibodies are present in 
the blood.
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